Not Yet Recruiting
Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML
NCT07493408
- Conditions
- Blastic Transformation of Chronic Myeloid Leukemia, Haematopoietic Stem Cell Transplant, Allogeneic, Ph+ Acute Lymphoblastic Leukemia (Ph+ALL), +1 more
- Locations
-
- The University of Hong Kong Hong Kong